Congratulations to Dr. Edward Ayoub for receiving an NIH F32 for his project entitled, "Targeting Quiescence Pathways to Overcome Chemoresistance in EVI1-Overexpressing Leukemia."
Edward also just received a scholarship from The Torsten Haferlach Leukemia Diagnostics Foundation. This scholarship is providing him with the opportunity to spend two months in Munich, Germany training at The Munich Leukemia Lab.
Congratulations to Dr. Marta Sans on receipt of the Harold C. and Mary L. Dailey Endowed Fellowship Grant. This award supports Postdoctoral Fellows and GME Trainees who have made significant research contributions, inventions, or discoveries during their training, and who demonstrate a promise of providing future significant scientific contributions within their fields of study.
Congratulations to Dr. Sofia Mastoraki (left) on receipt of the AACR-Doreen J. Putrah Cancer Research Foundation Scholar-in-Training Award for her abstract entitled, "Single-cell transcriptomic analysis of HR+/HER2- breast cancer identifies gene signatures that predict outcomes of luminal A and B subtypes"
Congratulations to TRIUMPH alum, Dr. Nicole Kettner (right) for receipt of the AACR-John and Elizabeth Leonard Family Foundation Scholar-in-Training Award for her abstract entitled, "Circulating IL-6, an early biomarker in HR-positive, HER2-negative metastatic breast cancer patients progressing on CDK4/6 inhibitors"
Congratulations to Drs. Nicole Kettner and Sofia Mastoraki for receiving translational research oral presentation awards at Trainee Research Day!
Congratulations to Dr. Sofia Mastoraki whose abstract entitled "LMW-E induction and crosstalk with immune cells potentiates local immune responses leading to an immunosuppressive microenvironment at the early stages of breast tumorigenesis in mouse models" was selected for an oral presentation at the 2022 FlowTex Hybrid Cytometry Conference.
The CPRIT TRIUMPH Program congratulates alumni Dr. Samantha Fix. Dr. Fix currently works for National Resilence, Inc., which together with MD Anderson, has launched the Cell Therapy Manufacturing Center. Please check out the press release below for more information on this exciting new venture.